about
Clinical implications of the intrinsic molecular subtypes of breast cancerOutpatient management of pulmonary embolism in cancer: data on a prospective cohort of 138 consecutive patients.Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer.Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy.Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma.Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab.Correlation of 18F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer.Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma.Life-threatening colitis and complete response with ipilimumab in a patient with metastatic BRAF-mutant melanoma and rheumatoid arthritis.Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer.Prognostic value of (18)F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer
P50
Q26800996-78EEFF29-4443-434C-9137-596F3C1CD073Q30774948-5051C2E9-2AB7-4D40-9559-C784183C61DBQ33591751-7AF6039B-EC97-4338-9AA0-D286D4C07D5AQ36383626-59D2BB62-CC7B-4546-89D8-5766D84C602CQ38825707-42663D7A-EE93-46E3-997D-FBB3B477BD8BQ39821273-5BE5B233-8A00-4D85-90E6-02E02A4AB4FCQ50226050-3EA70D5F-29C0-43E1-8314-2D7D0C9A50B3Q54196202-2F21B662-0EE8-4B05-AF5E-8F8C29749BF4Q54856582-5BEBB508-BB7E-4A13-AF97-034A6FE1625FQ54979063-BFCD8A2E-A994-45D0-BEC5-1BF0374C7FD9Q86633571-90DCCF21-AA6A-415C-A031-19B12AC92FA7
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
A Fernandez-Martinez
@ast
A Fernandez-Martinez
@en
A Fernandez-Martinez
@es
A Fernandez-Martinez
@nl
A Fernandez-Martinez
@sl
type
label
A Fernandez-Martinez
@ast
A Fernandez-Martinez
@en
A Fernandez-Martinez
@es
A Fernandez-Martinez
@nl
A Fernandez-Martinez
@sl
prefLabel
A Fernandez-Martinez
@ast
A Fernandez-Martinez
@en
A Fernandez-Martinez
@es
A Fernandez-Martinez
@nl
A Fernandez-Martinez
@sl
P106
P1153
57038515700
P31
P496
0000-0002-2311-4356